Hypertension

Intensive Blood-Pressure Lowering in Patients with Type 2 Diabetes

N Engl J MedPublished multicenter, open-label, randomized trial

Primary result · Composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina or heart failureResult — go to the resultHazard ratio 0.90 95% CI 0.77–1.06

Authors' conclusion

Among patients with type 2 diabetes, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, did not reduce the occurrence of major cardiovascular events. (Funded by Hospital Israelita Albert Einstein and the Brazilian Ministry of Health; OPTIMAL-DIABETES ClinicalTrials.gov number, NCT04040634.).

Study context

Population
Patients with elevated blood pressure, type 2 diabetes, and high cardiovascular risk
Participants
9,476 patients
Comparison
Intensive therapy vs standard therapy
  • Intensive therapyn = 4,745
  • Standard therapyn = 4,731reference
Primary endpoint
Composite of:
  • Death from cardiovascular causes
  • Nonfatal myocardial infarction
  • Nonfatal stroke
  • Hospitalization for unstable angina or heart failure
Follow-up
Median 4.0 years (interquartile range, 3.9 to 4.0)
Methodological detailsconducted in Brazil
  • Conducted in Brazil

Primary result

As reported in the abstract

Composite of death from cardiovascular causes, nonfatal myocardial infarction, nonfatal stroke, or hospitalization…

Hazard ratio

0.90

95% CI 0.77–1.06

P = 0.20

Events by treatment group

Intensive therapyvs Standard therapy
hazard ratio 0.90 (95% CI 0.77–1.06); P = 0.20

Further findings

Mean systolic blood pressure during follow-up (with exclusion of the first 3 months)

Baseline characteristics

Mean (±SD) age
64.7±8.2 years
Women
5871 of the patients (62.0%)

Safety

Serious adverse events

Original publication

Intensive Blood-Pressure Lowering in Patients with Type 2 Diabetes. N Engl J Med. Published 7 November 2026. doi:10.1056/nejmoa2612922

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.